Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding

NCT00389935 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

FED

Sponsor class

Conditions

Arteriovenous Malformation
Hereditary Hemorrhagic Telangiectasia
Hematochezia
Melena

Interventions

DRUG: Thalidomide

Sponsor

Northport Veterans Affairs Medical Center

Collaborators

[object Object]
[object Object]